Cargando…
Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes
Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); rutheni...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876511/ https://www.ncbi.nlm.nih.gov/pubmed/35215281 http://dx.doi.org/10.3390/ph15020169 |
_version_ | 1784658192358178816 |
---|---|
author | Komarnicka, Urszula K. Niorettini, Alessandro Kozieł, Sandra Pucelik, Barbara Barzowska, Agata Wojtala, Daria Ziółkowska, Aleksandra Lesiów, Monika Kyzioł, Agnieszka Caramori, Stefano Porchia, Marina Bieńko, Alina |
author_facet | Komarnicka, Urszula K. Niorettini, Alessandro Kozieł, Sandra Pucelik, Barbara Barzowska, Agata Wojtala, Daria Ziółkowska, Aleksandra Lesiów, Monika Kyzioł, Agnieszka Caramori, Stefano Porchia, Marina Bieńko, Alina |
author_sort | Komarnicka, Urszula K. |
collection | PubMed |
description | Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); ruthenium(II) complexes: Ru(η6-p-cymene)Cl(2)(1) (1b), Ru(η6-p-cymene)Cl(2)(2) (2b) and copper(I) complexes: [Cu(CH(3)CN)(2)(1)BF(4)] (1c), [Cu(CH(3)CN)(2)(2)BF(4)] (2c) were synthesized and characterized using elemental analysis, NMR spectroscopy, and ESI-MS spectrometry. Copper(I) complexes turned out to be highly unstable in the presence of atmospheric oxygen in contrast to ruthenium(II) and iridium(III) complexes. The studied Ru(II) and Ir(III) complexes exhibited promising cytotoxicity towards cancer cells in vitro with IC(50) values significantly lower than that of the reference drug—cisplatin. Confocal microscopy analysis showed that Ru(II) and Ir(III) complexes effectively accumulate inside A549 cells with localization in cytoplasm and nuclei. A precise cytometric analysis provided clear evidence for the predominance of apoptosis in induced cell death. Furthermore, the complexes presumably induce the changes in the cell cycle leading to G2/M phase arrest in a dose-dependent manner. Gel electrophoresis experiments revealed that Ru(II) and Ir(III) inorganic compounds showed their unusual low genotoxicity towards plasmid DNA. Additionally, metal complexes were able to generate reactive oxygen species as a result of redox processes, proved by gel electrophoresis and cyclic voltamperometry. In vitro cytotoxicity assays were also carried out within multicellular tumor spheroids and efficient anticancer action on these 3D assemblies was demonstrated. It was proven that the hydrocarbon chain elongation of the phosphine ligand coordinated to the metal ions does not influence the cytotoxic effect of resulting complexes in contrast to metal ions type. |
format | Online Article Text |
id | pubmed-8876511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88765112022-02-26 Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes Komarnicka, Urszula K. Niorettini, Alessandro Kozieł, Sandra Pucelik, Barbara Barzowska, Agata Wojtala, Daria Ziółkowska, Aleksandra Lesiów, Monika Kyzioł, Agnieszka Caramori, Stefano Porchia, Marina Bieńko, Alina Pharmaceuticals (Basel) Article Two novel phosphine ligands, Ph(2)PCH(2)N(CH(2)CH(3))(3) (1) and Ph(2)PCH(2)N(CH(2)CH(2)CH(2)CH(3))(2) (2), and six new metal (Cu(I), Ir(III) and Ru(II)) complexes with those ligands: iridium(III) complexes: Ir(η5-Cp*)Cl(2)(1) (1a), Ir(η5-Cp*)Cl(2)(2) (2a) (Cp*: Pentamethylcyclopentadienyl); ruthenium(II) complexes: Ru(η6-p-cymene)Cl(2)(1) (1b), Ru(η6-p-cymene)Cl(2)(2) (2b) and copper(I) complexes: [Cu(CH(3)CN)(2)(1)BF(4)] (1c), [Cu(CH(3)CN)(2)(2)BF(4)] (2c) were synthesized and characterized using elemental analysis, NMR spectroscopy, and ESI-MS spectrometry. Copper(I) complexes turned out to be highly unstable in the presence of atmospheric oxygen in contrast to ruthenium(II) and iridium(III) complexes. The studied Ru(II) and Ir(III) complexes exhibited promising cytotoxicity towards cancer cells in vitro with IC(50) values significantly lower than that of the reference drug—cisplatin. Confocal microscopy analysis showed that Ru(II) and Ir(III) complexes effectively accumulate inside A549 cells with localization in cytoplasm and nuclei. A precise cytometric analysis provided clear evidence for the predominance of apoptosis in induced cell death. Furthermore, the complexes presumably induce the changes in the cell cycle leading to G2/M phase arrest in a dose-dependent manner. Gel electrophoresis experiments revealed that Ru(II) and Ir(III) inorganic compounds showed their unusual low genotoxicity towards plasmid DNA. Additionally, metal complexes were able to generate reactive oxygen species as a result of redox processes, proved by gel electrophoresis and cyclic voltamperometry. In vitro cytotoxicity assays were also carried out within multicellular tumor spheroids and efficient anticancer action on these 3D assemblies was demonstrated. It was proven that the hydrocarbon chain elongation of the phosphine ligand coordinated to the metal ions does not influence the cytotoxic effect of resulting complexes in contrast to metal ions type. MDPI 2022-01-29 /pmc/articles/PMC8876511/ /pubmed/35215281 http://dx.doi.org/10.3390/ph15020169 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Komarnicka, Urszula K. Niorettini, Alessandro Kozieł, Sandra Pucelik, Barbara Barzowska, Agata Wojtala, Daria Ziółkowska, Aleksandra Lesiów, Monika Kyzioł, Agnieszka Caramori, Stefano Porchia, Marina Bieńko, Alina Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title | Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title_full | Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title_fullStr | Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title_full_unstemmed | Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title_short | Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu(I), Ru(II), Ir(III) Complexes |
title_sort | two out of three musketeers fight against cancer: synthesis, physicochemical, and biological properties of phosphino cu(i), ru(ii), ir(iii) complexes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876511/ https://www.ncbi.nlm.nih.gov/pubmed/35215281 http://dx.doi.org/10.3390/ph15020169 |
work_keys_str_mv | AT komarnickaurszulak twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT niorettinialessandro twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT koziełsandra twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT pucelikbarbara twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT barzowskaagata twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT wojtaladaria twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT ziołkowskaaleksandra twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT lesiowmonika twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT kyziołagnieszka twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT caramoristefano twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT porchiamarina twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes AT bienkoalina twooutofthreemusketeersfightagainstcancersynthesisphysicochemicalandbiologicalpropertiesofphosphinocuiruiiiriiicomplexes |